InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-33.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Longsworth Todd Christopher, Conseiller Juridique. Director active across 1 company, notably NovoCure Ltd. Aggregated, 4 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €224k. History available since 6 July 2021. The latest transaction was filed on 8 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
2,339 shares@ US$70.100.010% mcap58.0% of flowOrdinary SharesSEC:0001645113-22-000025:0
1,094 shares@ US$74.4980.0050% mcap28.2% of flowOrdinary SharesSEC:0001645113-22-000023:0
154 shares@ US$137.1220.0012% mcap6.9% of flowOrdinary SharesSEC:0001645113-21-000082:0
154 shares@ US$137.1226.9% of flowOrdinary SharesSEC:0001645113-21-000082
4 of 4 declarations
About Longsworth Todd Christopher
Todd Christopher Longsworth is the General Counsel at NovoCure Ltd. He is responsible for managing the company's legal affairs, including compliance and regulatory issues. With expertise in business law, he plays an essential role in protecting NovoCure's interests and managing legal risks. His experience contributes to the overall strategy of the company.
